This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Manlius, NY (US) (2017 - 2018)
- Pepperell, MA (US) (2018 - 2023)
Company Filing History:
Years Active: 2017-2023
Title: Yueming Qian: Innovator in Bioprocessing and Immunology
Introduction
Yueming Qian is a prominent inventor based in Pepperell, MA (US), known for his significant contributions to the fields of bioprocessing and immunology. With a total of five patents to his name, Qian has made strides in developing innovative solutions that enhance protein production and improve bioanalytical properties.
Latest Patents
Among his latest patents is the development of a therapeutic immunoglobulin G4 that boasts improved bioanalytical and bioprocessing properties. This invention includes an IgG4 antibody with specific modifications in the heavy chain, aimed at enhancing its functionality. Another notable patent focuses on mammalian cell culture processes for protein production, detailing methods that utilize glucocorticoid compounds to sustain cell viability and increase the yield and quality of glycoproteins.
Career Highlights
Yueming Qian is currently associated with Bristol-Myers Squibb Company, where he applies his expertise in biopharmaceutical development. His work has been instrumental in advancing methodologies that are crucial for the production of therapeutic proteins.
Collaborations
Qian has collaborated with notable colleagues, including Zhengjian Li and Ying Jing, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yueming Qian's work exemplifies the intersection of innovation and practical application in the biopharmaceutical industry. His patents reflect a commitment to enhancing the efficacy of therapeutic products, making a lasting impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
